HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The level of Hb F-Sardinia (alpha 2A gamma 2(75)Ile----Thr) in the fetal hemoglobin of Sardinian beta-thalassemic homozygotes determined by isoelectric focusing.

Abstract
A simple thin-layer isoelectric focusing technique was used to separate Hb F-Sardinia, containing the A gamma T-globin chain, from the Hb F containing the G gamma- and the A gamma I-globin chains. The identity of the slow-moving Hb F fraction as Hb F-Sardinia was verified by PAGE. A negative correlation (R2 = 0.747, p less than 0.001) was found between the percent Hb F-Sardinia and percent G gamma-chain in homozygotes for beta-thalassemia. Of 31 Sardinian beta-thalassemic patients studied, 21 were homozygous and eight heterozygous for the A gamma T polymorphism with a gene frequency of 0.823. The mean values of Hb F-Sardinia were 39.1 +/- 5.9% for the homozygotes and 17.1 +/- 3.6% for the heterozygotes. The percentage of Hb F-Sardinia found in beta o-thalassemic newborns was similar to that of corresponding normal newborns who also had the A gamma T polymorphism. No measurable differences in the percent Hb F-Sardinia level were observed among beta o-thal patients who were polytransfused, beta o-thal patients studied before transfusion, and beta o-thal patients exhibiting the intermediate form of the disease who had never been transfused.
AuthorsB Masala, L Manca, M Formato, A Matera
JournalAmerican journal of hematology (Am J Hematol) Vol. 21 Issue 4 Pg. 367-76 (Apr 1986) ISSN: 0361-8609 [Print] United States
PMID2420171 (Publication Type: Journal Article)
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin F Sardinia
  • Globins
  • Fetal Hemoglobin
Topics
  • Blood Protein Electrophoresis
  • Blood Transfusion
  • Fetal Hemoglobin (analysis)
  • Gene Frequency
  • Globins (genetics)
  • Hemoglobins, Abnormal (analysis)
  • Homozygote
  • Humans
  • Infant
  • Infant, Newborn
  • Isoelectric Focusing
  • Polymorphism, Genetic
  • Thalassemia (blood, genetics, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: